Celularity Inc

SEC 8-K · Filed

0001493152-26-009017Accepted

Applies to the EDGAR acceptance time.

Other time zone
Leadership changesItem 5.02

John Sprague — appointed as Chief Financial Officer

appointed John Sprague as Acting Chief Financial Officer
Structured facts
{
  "action": "appointed",
  "evidence": "appointed John Sprague as Acting Chief Financial Officer",
  "person": "John Sprague",
  "role": "Chief Financial Officer"
}